Back to Search Start Over

Modeling the Cost-Effectiveness of Home-Based HIV Testing and Education (HOPE) for Pregnant Women and Their Male Partners in Nyanza Province, Kenya.

Authors :
Sharma, Monisha
Farquhar, Carey
Ying, Roger
Krakowiak, Daisy
Kinuthia, John
Osoti, Alfred
Asila, Victor
Gone, Molly
Mark, Jennifer
Barnabas, Ruanne V.
Source :
JAIDS: Journal of Acquired Immune Deficiency Syndromes. 2016 Supplement 2, Vol. 72, pS174-S180. 7p.
Publication Year :
2016

Abstract

Introduction: Women in sub-Saharan Africa face a 2-fold higher risk of HIV acquisition during pregnancy and postpartum and the majority do not know the HIV status of their male partner. Homebased couple HIV testing for pregnant women can reduce HIV transmission to women and infants while increasing antiretroviral therapy (ART) coverage in men. However, the cost-effectiveness of this program has not been evaluated. Methods: We modeled the health and economic impact of implementing a home-based partner education and HIV testing (HOPE) intervention for pregnant women and their male partners in a region of Western Kenya (formally Nyanza Province). We used data from the HOPE randomized clinical trial conducted in Kisumu, Kenya, to parameterize a mathematical model of HIV transmission. We conducted an in-country microcosting of the HOPE intervention (payer perspective) to estimate program costs as well as a lower cost scenario of task-shifting to community health workers. Results: The incremental cost of adding the HOPE intervention to standard antenatal care was $31-37 and $14-16 USD per couple tested with program and task-shifting costs, respectively. At 60% coverage of male partners, HOPE was projected to avert 6987 HIV infections and 2603 deaths in Nyanza province over 10 years with an incremental cost-effectiveness ratio (ICER) of $886 and $615 per disability-adjusted life year averted for the program and task-shifting scenario, respectively. ICERs were robust to changes in intervention coverage, effectiveness, and ART initiation and dropout rates. Conclusions: The HOPE intervention can moderately decrease HIV-associated morbidity and mortality by increasing ART coverage in male partners of pregnant women. ICERs fall below Kenya's per capita gross domestic product ($1358) and are therefore considered cost-effective. Task-shifting to community health workers can increase intervention affordability and feasibility. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
15254135
Volume :
72
Database :
Academic Search Index
Journal :
JAIDS: Journal of Acquired Immune Deficiency Syndromes
Publication Type :
Academic Journal
Accession number :
117787812
Full Text :
https://doi.org/10.1097/QAI.0000000000001057